Atlantic Therapeutics
Creates a non-invasive pelvic floor exerciser which strengthens the pelvic floor muscles and modulates the nerves.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
| EUR | 2019 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Atlantic Therapeutics operates in the medical device industry, focusing on non-invasive solutions for stress urinary incontinence. The company's flagship product, INNOVO, utilizes Electrical Muscle Stimulation (EMS) to strengthen and re-educate the pelvic floor muscles, providing a clinically proven method to treat bladder weakness. INNOVO is designed for both men and women of all ages and is easy to use, featuring a pull-on shorts design made from breathable, skin-friendly material.
The device is controlled via a handheld controller, allowing users to adjust the intensity of muscle stimulation. The product has shown significant efficacy, with 80% of users experiencing improvement within 4 weeks and 87% achieving dryness or near dryness after 12 weeks. Atlantic Therapeutics also emphasizes sustainability, holding a Green Dot license and contributing to the end recovery of its packaging. The company generates revenue through direct sales of its INNOVO device and potentially through partnerships with healthcare providers.
Keywords: Medical device, stress urinary incontinence, Electrical Muscle Stimulation, pelvic floor, non-invasive, bladder weakness, clinically proven, sustainability, user-friendly, healthcare.